# RSV-F Vaccine and Influenza Vaccine Co-Administration Study in the Elderly

> **NCT01709019** · PHASE1 · COMPLETED · sponsor: **Novavax** · enrollment: 220 (actual)

## Conditions studied

- Respiratory Syncytial Virus (RSV)

## Interventions

- **BIOLOGICAL:** Low dose RSV-F Vaccine with Adjuvant (Day 0); Seasonal TIV (Day 0 & Day 28)
- **BIOLOGICAL:** Low dose RSV-F Vaccine without Adjuvant (Day 0); Seasonal TIV (Day 0 & day 28)
- **BIOLOGICAL:** High dose RSV-F Vaccine with Adjuvant (Day 0); Seasonal TIV (Day 0 & Day 28)
- **BIOLOGICAL:** High dose RSV-F Vaccine without Adjuvant (Day 0); Seasonal TIV (Day 0 & Day 28)
- **BIOLOGICAL:** Placebo (Day 0 & Day 28); Seasonal TIV (Day 0)

## Key facts

- **NCT ID:** NCT01709019
- **Lead sponsor:** Novavax
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-10
- **Primary completion:** 2013-07
- **Final completion:** 2014-03
- **Target enrollment:** 220 (ACTUAL)
- **Last updated:** 2014-03-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01709019

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01709019, "RSV-F Vaccine and Influenza Vaccine Co-Administration Study in the Elderly". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01709019. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*